← Open Payments lookup

WILLIAM TALLMADGE: Open Payments

NPI 1912080813 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,089 in 109 payments from 26 companies in 2025. Trend: 2023 $1,292 · 2024 $1,442 · 2025 $2,089

Food & beverage: $2,010Education: $79
CompanyPaymentsAmount
GlaxoSmithKline, LLC.39$567
GENZYME CORPORATION9$249
AstraZeneca Pharmaceuticals LP8$174
Insmed, Inc.8$174
Actelion Pharmaceuticals US, Inc.3$129
Boehringer Ingelheim Pharmaceuticals, Inc.4$83
Electromed, Inc.5$68
ABBVIE INC.3$64
Takeda Pharmaceuticals U.S.A., Inc.3$62
VERTEX PHARMACEUTICALS INCORPORATED3$62

Products named: DUPIXENT, TRELEGY ELLIPTA, NUCALA, Arikayce, OPSUMIT, AIRSUPRA, SMARTVEST, GLASSIA.

Industry payments across TX — which companies pay providers there.